May 2025 in “InnovAiT Education and inspiration for general practice” This abstract notes that while treatments like minoxidil and finasteride are effective for preventing further hair loss, they require continuous use, have limited efficacy in reversing baldness, and have possible side effects.
March 2025 in “Meditsinskiy sovet = Medical Council” In this article, researchers explore the causes, diagnostic approaches, and treatment strategies for diffuse telogen alopecia, emphasizing the importance of identifying triggers such as stress and metabolic disorders to effectively manage this hair loss condition.
March 2025 in “MAEDICA – a Journal of Clinical Medicine” This review explores the potential impact of SARS-CoV-2 on benign prostatic hyperplasia and related lower urinary tract symptoms but reports no new clinical results, emphasizing the need for further studies to quantify these changes.
February 2025 in “International Journal of Pharmaceutical Research and Applications” This article reviews the symptoms, diagnosis, and management of polycystic ovary syndrome, emphasizing lifestyle changes and medical interventions, but presents no new findings.
December 2024 in “International Journal of Advanced Research in Science Communication and Technology” In this study, researchers prepared a herbal hair tonic using virgin coconut oil and nine herbs, evaluating its antibacterial, antifungal activities, and benefits for hair strength, with variations in ingredient concentrations and analyses for consistency and appearance.
November 2024 in “Huisarts en Wetenschap” Telogen effluvium hair loss often resolves on its own in 3 to 6 months, but see a dermatologist if it persists.
November 2024 in “Deleted Journal” This study assessed zinc concentrations in breast milk from 58 Palestinian lactating women and found that breast milk zinc levels varied with demographics such as age, urban living, employment status, and intake of zinc-rich drinks.
October 2024 in “Benha Journal of Applied Sciences” This study of fifty female patients with frontal fibrosing alopecia in Egypt found that it is a complex condition with no definitive treatment, as it often co-occurs with lichen planus and thyroid issues.
October 2024 in “Aesthetic Cosmetology and Medicine” This study examined the potential benefits of incorporating cannabis-derived compounds like cannabidiol and seed oil into skincare products, finding they may improve skin health and address inflammation and dermatological issues, thus supporting their role in developing effective cosmeceuticals.
September 2024 in “JEADV Clinical Practice” In this study, researchers analyzed French social media posts and found that alopecia areata profoundly impacts patients' quality of life, affecting them physically, psychologically, socially, and financially, often driving them to seek support online.
July 2024 in “Journal of Investigative Dermatology” In this animal study, researchers found that the simultaneous deletion of ERBB2 and ERBB3 in mice results in impaired skin differentiation, inflammation, and sebaceous gland alteration, leading to skin lesions, while highlighting potential side effects in cancer therapies targeting these receptors.
June 2024 in “British Journal of Dermatology” This article presents a family case study of dermatopathia pigmentosa reticularis linked to a specific KRT14 gene variant, detailing symptoms and stressing the importance of molecular diagnosis for management.
June 2024 in “Biological and Clinical Sciences Research Journal” In this study, researchers found that women with PCOS and thyroid dysfunction had significantly altered T3 and T4 hormone levels and more frequent symptoms like weight gain and irregular menstrual cycles, suggesting the importance of thyroid screenings for personalized treatment strategies.
June 2024 in “Journal of Clinical Oncology” This study examined the FDA Adverse Events Reporting System and found new dermatologic adverse events associated with EGFR-TKIs in non-small cell lung cancer patients, such as specific skin, nail, and hair issues, that aren't currently listed on drug labels.
In this study, researchers found a strong association between premature graying of hair and deficiencies in vitamin D and B12, hypothyroidism, and deranged iron profiles, along with higher stress, altered appetite, smoking, and sleep pattern issues, significantly impacting quality of life.
April 2024 in “Nigerian Postgraduate Medical Journal” This review summarizes existing knowledge on androgenetic alopecia, including its epidemiology, pathophysiology, and management, but presents no new research findings.
April 2024 in “Women s Health Reports” This study explored the clinical and biochemical hyperandrogenic status in adolescents with irregular menses to identify significant indicators of potential metabolic problems linked to PCOS.
March 2024 in “CRC Press eBooks” This article discusses the psychosocial impact of androgenetic alopecia and does not report new findings; it highlights the perceived effects of hair loss on self-esteem and confidence.
March 2024 in “Nevşehir Hacı Bektaş Veli Üniversitesi SBE Dergisi” In this study, a child with Alopecia Areata underwent art therapy, leading to reduced anxiety and stress levels and improved emotional expression and motivation for treatment, suggesting art therapy as a suitable psychosocial intervention for this condition.
This review explores the risk factors, associated comorbidities, and psychological impacts of early-onset androgenetic alopecia, highlighting its complexity and potential implications for treatment response and overall health.
In this study, nearly 38% of Saudi women with PCOS reported extremely severe depression and extreme anxiety, with higher rates linked to young age, divorce, lifestyle advice, and higher BMI.
January 2024 in “JAAD case reports” Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.
January 2024 in “Medical Research Archives” This source highlights the emerging field of psychodermatology, which examines the interplay between psychological factors and skin disorders, noting a historical lack of attention due to inadequate professional training and emphasizing the need for integrated care involving dermatologists, psychiatrists, and psychologists.
December 2023 in “Health economics and management review” In this descriptive research conducted in Tirunelveli City, Tamil Nadu, the study identified common health problems among radiographers, including tiredness, body pain, and emotional disturbances, highlighting the need to address these issues to ensure accurate disease diagnosis and treatment in healthcare settings.
December 2023 in “Acta Facultatis Medicae Naissensis” This study reviews skin issues caused by COVID-19 and related measures, concluding that cosmeceuticals, positioned between cosmetics and pharmaceuticals, are widely recommended for managing these conditions unless they are severe.
November 2023 in “Frontiers in Neuroendocrinology” This study suggests that post-finasteride syndrome and post-SSRI sexual dysfunction share potential etiopathogenetic mechanisms involving brain modulators, neurotransmitters, and gut microbiota, although more research is needed to understand these conditions fully.
October 2023 in “Cognizance journal” This study explores using agent-based modeling and nutrition science to predict and treat oral and dental diseases as alternatives to traditional incarceration for managing criminal behavior, but results are not reported.
September 2023 in “Journal of the American Academy of Dermatology” Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.
June 2023 in “British Journal of Dermatology” This study observed that baricitinib treatment led to significant improvements in hair regrowth and quality of life scores in adults with severe alopecia areata over 24 weeks, with an acceptable safety profile as most adverse effects were transient.
May 2023 in “Australasian Journal of Dermatology” Results are not reported in this source. The abstract does not provide a summary or findings from the Australasian Journal of Dermatology regarding contact dermatitis.